Table 1.
Features | Description |
---|---|
Prevalence | 0.9%–12.1% |
Histopathology | Most common type (about two-thirds) is cholesterol polyps. Other lesions include inflammatory polyps, hyperplastic polyps, adenomyomatosis, adenomas, adenocarcinoma. |
Risk factors | Gender, age, hepatitis B virus infection, liver function abnormalities, fatty liver, dyslipidemia, overweight and obesity, number, shape and size of GPLs, metabolic syndrome, and ethnicity. |
Biological mechanism | Hormone levels in vivo, gut microbiota, inflammation, oxidative stress, Salmonella typhimurium, and related molecules. |
Natural history | Most of the small polyps were benign, with no change in number and size. |
Coexisting diseases | GallstonesPrimary sclerosing cholangitis |
Diagnosis | Including chemical examination and imaging examination. Imaging examination is mainly used at present, ultrasound is the common imaging method. |
Treatment | Cholecystectomy or gallbladder-preserving polyp resection was performed in patients with symptoms, large lesions (≥10 mm in diameter), or features associated with malignancy. |
GPLs: Gallbladder polypoid lesions.